Article ; Online: Immune evasion by oncogenic proteins of acute myeloid leukemia.
2014 Volume 123, Issue 10, Page(s) 1535–1543
Abstract: PML-RARA and AML1-ETO are important oncogenic fusion proteins that play a central role in transformation to acute myeloid leukemia (AML). Whether these fusion proteins render the tumor cells with immune evasion properties is unknown. Here we show that ... ...
Abstract | PML-RARA and AML1-ETO are important oncogenic fusion proteins that play a central role in transformation to acute myeloid leukemia (AML). Whether these fusion proteins render the tumor cells with immune evasion properties is unknown. Here we show that both oncogenic proteins specifically downregulate the expression of CD48, a ligand of the natural killer (NK) cell activating receptor 2B4, thereby leading to decreased killing by NK cells. We demonstrate that this process is histone deacetylase (HDAC)-dependent, that it is mediated through the downregulation of CD48 messenger RNA, and that treatment with HDAC inhibitors (HDACi) restores the expression of CD48. Furthermore, by using chromatin immunoprecepitation (ChIP) experiments, we show that AML1-ETO directly interacts with CD48. Finally, we show that AML patients who are carrying these specific translocations have low expression of CD48. |
---|---|
MeSH term(s) | Antigens, CD/chemistry ; Antigens, CD/genetics ; Antigens, CD/metabolism ; Base Sequence ; CD48 Antigen ; Cell Line, Tumor ; Core Binding Factor Alpha 2 Subunit/genetics ; Core Binding Factor Alpha 2 Subunit/immunology ; Cytotoxicity, Immunologic ; Gene Expression ; Gene Expression Regulation ; Histone Deacetylases/metabolism ; Humans ; Killer Cells, Natural/immunology ; Killer Cells, Natural/metabolism ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/immunology ; Leukemia, Myeloid, Acute/metabolism ; Molecular Sequence Data ; Oncogene Proteins, Fusion/genetics ; Oncogene Proteins, Fusion/immunology ; Oncogene Proteins, Fusion/metabolism ; RUNX1 Translocation Partner 1 Protein ; Tumor Escape/genetics ; Tumor Escape/immunology |
Chemical Substances | AML1-ETO fusion protein, human ; Antigens, CD ; CD48 Antigen ; CD48 protein, human ; Core Binding Factor Alpha 2 Subunit ; Oncogene Proteins, Fusion ; RUNX1 Translocation Partner 1 Protein ; promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein ; Histone Deacetylases (EC 3.5.1.98) |
Language | English |
Publishing date | 2014-01-21 |
Publishing country | United States |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 80069-7 |
ISSN | 1528-0020 ; 0006-4971 |
ISSN (online) | 1528-0020 |
ISSN | 0006-4971 |
DOI | 10.1182/blood-2013-09-526590 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uh III Zs.140: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 364: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.